We could not find any results for:
Make sure your spelling is correct or try broadening your search.
BioSenic S.A. : Transparency notifications received from François Rieger PRESS RELEASE – REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...
BioSenic provides further information on its restructuring plan PRESS RELEASE - PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 12 April 2024, 12:00 CET – BioSenic (Euronext Brussels...
BioSenic and its restructuring practitioner (Me Yves Brulard) submit a global restructuring plan covering the years 2024-2030 to the Enterprise Court of Nivelles PRESS RELEASE - PRIVILEGED...
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 mars 2024 à 07h00...
BioSenic presents successful preclinical data on its ATO medication for controlling key symptoms at the 2024 Systemic Sclerosis World Congress PRESS RELEASE Preclinical data in a transgenic mouse...
BioSenic présente des données précliniques concluantes sur son médicament ATO pour le contrôle des principaux symptômes au Congrès mondial 2024 sur la sclérose systémique COMMUNIQUE DE PRESSE Des...
BioSenic releases details of optimized administration approach ahead of planned Phase 3 trial of OATO for chronic graft-versus-host disease INSIDE INFORMATION New data builds on earlier findings...
BioSenic publie les détails de la stratégie d'administration optimisée pour OATO dans le traitement de la maladie chronique du greffon contre l'hôte en amont du prochain essai de phase 3...
BioSenic S.A. : Information relative au nombre total de droits de vote et d’actions COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 29 février 2024 à 07h00 CEST...
BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 29 February 2024, 7.00 am CEST – BIOSENIC (Euronext...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.845 | 3.845 | 3.845 | 1792 | 3.845 | DE |
4 | 0 | 0 | 3.845 | 3.845 | 3.845 | 6420 | 3.845 | DE |
12 | 0 | 0 | 3.845 | 3.845 | 3.845 | 9379 | 3.845 | DE |
26 | 0 | 0 | 3.845 | 3.845 | 3.845 | 11724 | 3.845 | DE |
52 | 0 | 0 | 3.845 | 3.845 | 3.845 | 23916 | 3.845 | DE |
156 | 0 | 0 | 3.845 | 3.845 | 3.845 | 11475 | 3.845 | DE |
260 | 0 | 0 | 3.845 | 3.845 | 3.845 | 11294 | 3.845 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions